Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2016 Dec 5;24(11):2033. doi: 10.1038/mt.2016.196

Corrigendum to “Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma”

PMCID: PMC5154492  PMID: 27916990

Mikko Siurala, Riikka Havunen, Dipongkor Saha, Dave Lumen, Anu J. Airaksinen,

Siri Tähtinen, Víctor Cervera-Carrascon, Simona Bramante, Suvi Parviainen, Markus Vähä-Koskela,

Anna Kanerva, and Akseli Hemminki

Molecular Therapy (2016) 24: 1435–1443. doi:10.1038/mt.2016.134

Following publication, it was noted that the y-axis in Figure 5b was mislabeled as “CD8+CD3+ expressing PD-L1.” The correct label is “CD8+CD3+ expressing PD1.”


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES